Norstella

Norstella introduces NorstellaLinQ: https://ow.ly/nqga50TGawG. It's biopharma’s first fully integrated data asset combining RWD—open and closed claims, lab results and EMR—with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data. Get closer to the patient than ever before. Learn more about NorstellaLinQ at the link in this post.

We did it! Norstella is thrilled to be named "Company of the Year" by the Business Intelligence Group in the 2024 BIG Awards for Business. https://ow.ly/NXwP50UbhZa This prestigious recognition highlights our relentless efforts to reshape our industry and our unwavering commitment to smoothing the path to lifesaving therapies for patients and providers. Learn more in the news release from Business Intelligence Group: https://ow.ly/Jmwn50UbhZ9.

https://ow.ly/CKG750UapAa Discover how leading pharmaceutical companies leverage MMIT's powerful Analytics platform to gain seamless access to comprehensive formulary information, medical policies, and restriction details. Download our case studies to see how our user-friendly technology drives industry success at the link in this post.

Employee Spotlight: Meet Melody Marden https://ow.ly/NHGw50U7tE9 Melody is an industry veteran who currently holds the role of Vice President, Custom Solutions at Evaluate Ltd. While Melody has had a long and diverse career in healthcare, working across the spectrum of pharma and life science organizations, she has always stayed true to her driving mantra: Strive to make a difference. View the full Q&A at the link in this post. #FollowNorstella #Pipeline2Patient

??SMBC Nikko Securities × CITELINE collabo webinar?? ~Clinical Trends in nucleic-acids-therapeutics~ *Japanese webinar The SMBC Nikko Securities collaboration webinar, which was attended by over 1000 people last time, will be held on the topic of 【nucleic acid medicine】. Mr. Jiro Fujiyasu, Director of Pharmaceuticals & Healthcare, Industry Research Department, SMBC Nikko Securities Inc. will give a presentation on the latest trends in nucleic acid drugs from an expert's perspective. 〇date; 27th Dec 2PM JST 〇registration; zoom[free] 〇language; japanese Details HERE ; https://lnkd.in/gtjTQ5eF

Patient access is a critical challenge in the US pharma industry, impacting the pace of drug development and the delivery of life-saving treatments. To assess the current state of patient access, Norstella’s MMIT (Managed Markets Insight & Technology) surveyed over 300 industry professionals to uncover key trends and challenges. Watch this video to discover the survey’s key findings, and download the full MMIT Patient Access Report: https://ow.ly/W3a350TA62U. #Pipeline2Patient #FollowNorstella

We arrived in Barcelona and look forward to kicking off an excellent #ISPOREurope conference tomorrow! https://ow.ly/NTr350TMCgW Stop by booth 403 anytime from 9:30 a.m. to 7 p.m. tomorrow to chat with us or grab a pick-me-up of all-day coffee and pastries. We look forward to seeing many of you there!

At Norstella, we unite powerhouse companies—Evaluate, MMIT, Panalgo, Citeline, and The Dedham Group—with one shared mission: to improve patient access to therapies. With cutting-edge tools like real-world data, machine learning, and predictive analytics, we don’t just provide information; we deliver answers that drive action. Now, we’re looking for a RWD Business Analyst to join our amazing Real-World Data Engagement Team! ?? What you'll do: ? Dive deep into claims, lab results, and EMRs to uncover game-changing insights. ? Collaborate with the most brilliant minds in the industry to tackle our clients' toughest challenges. ? Transform raw data into meaningful strategies that improve patient care. Why join us?: This isn’t just a job—it’s a chance to make a real impact on healthcare. If you're passionate about sleuthing through data, solving big problems, and helping patients get the treatments they need, we want to hear from you! Bring your SQL skills, love for analytics, and understanding of the U.S. healthcare system, and let’s do great things together ???? Let's chat! #RealWorldData #RWD #HealthcareAnalytics Norstella MMIT (Managed Markets Insight & Technology) Panalgo Citeline Evaluate Ltd The Dedham Group https://lnkd.in/gP9XiSYC

Conference Catch-Up: Navigating the Evolving CDMO Landscape - Listen now: https://ow.ly/u6MY50U5a9N CDMOs are transforming pharmaceutical production and boosting supply chain resilience and innovation. At CPHI Milan, our team observed key industry trends, including sustainability and supply chain innovation advancements, while celebrating excellence at Citeline's Global Generics & Biosimilars Awards. In this episode, Andrea Charles, Andrew Warmington, and Izabela Chmielewska discuss takeaways – from the BIOSECURE Act to biomanufacturing progress – showing how Norstella supports the journey from pipeline to patient.

Missed BIO-Europe? https://ow.ly/KZmb50U4I2i If you'd like to catch up on the hot topics and what they mean for pharma as we head into 2025, join Evaluate's live webinar on 14 November. Daniel Chancellor and Melanie Senior will discuss key themes and answer your questions. Book your place now!